FOXO · Foxo Technologies Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.17M | - | $3.55M | $5.22M | $3.17M | - | $1.20M | $28.0K | $7.0K | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | $35.5K | - | $77.1K | $40.2K | $30.0K | - | $43.0K | $104.0K | $165.0K | - |
| SG&A | $2.88M | - | $2.47M | $2.62M | $2.76M | - | $1.73M | $1.47M | $988.0K | - |
| Total Operating Expenses | $5.44M | - | $4.41M | $4.65M | $4.72M | - | $2.20M | $1.62M | $1.19M | - |
| D&A | $171.1K | - | - | $2.3K | $143.0K | - | $17.0K | $247.0K | $260.0K | - |
| Operating Income | ($276.9K) | - | ($859.8K) | $567.1K | ($1.55M) | - | ($1.00M) | ($1.59M) | ($1.18M) | - |
| Interest Expense | $973.1K | - | $934.2K | $1.01M | $301.9K | - | $148.0K | $492.0K | $42.0K | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | ($1.45M) | - | ($1.88M) | ($522.0K) | ($616.5K) | - | ($1.95M) | ($2.16M) | ($1.50M) | - |
| EPS - Basic | - | - | - | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65.9K | $207.5K | $628.6K | $321.8K | $16.9K | $68.3K | $34.0K | $33.0K | $3.0K | $38.0K |
| Accounts Receivable | $3.91M | $2.47M | $3.16M | $4.92M | $2.65M | $2.27M | $2.00M | $276.0K | - | - |
| Inventory | $188.6K | $183.6K | $7.7K | - | - | $161.5K | - | - | - | - |
| Accounts Payable | $7.48M | $6.97M | $6.76M | $7.03M | $7.32M | $6.68M | $8.20M | $5.31M | $4.99M | $4.56M |
| Current Assets | $4.49M | $3.11M | $4.17M | $5.63M | $3.19M | $2.88M | $2.91M | $489.0K | $262.0K | $233.0K |
| Total Assets | $45.79M | $44.58M | $52.09M | $50.02M | $41.88M | $41.71M | $42.67M | $6.91M | $2.99M | $725.0K |
| Current Liabilities | $31.56M | $28.66M | $28.64M | $32.90M | $28.66M | $32.73M | $34.35M | $21.31M | $17.07M | $14.34M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $36.15M | $33.50M | $31.96M | $36.34M | $32.23M | $36.44M | $60.23M | $23.07M | $17.93M | $14.82M |
| Stockholders' Equity | $9.71M | $11.14M | $20.20M | $13.74M | $9.71M | $5.32M | ($17.51M) | ($16.13M) | ($14.94M) | ($14.10M) |
| Retained Earnings | ($226.10M) | ($224.64M) | ($206.26M) | ($192.12M) | ($191.33M) | ($190.54M) | ($183.73M) | ($181.69M) | ($179.22M) | ($177.06M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($577.9K) | - | - | - | ($1.34M) | - | - | - | $1.72M | - |
| Investing Cash Flow | ($4.0K) | - | - | - | - | - | - | - | ($2.12M) | - |
| Financing Cash Flow | $440.3K | - | - | - | $1.29M | - | - | - | $371.0K | - |
| CapEx | $4.0K | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | ($581.9K) | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | -5.4% | - | -24.2% | 10.9% | -48.8% | - | -84.0% | -5675.0% | -16842.9% | - |
| EBITDA margin | -2.0% | - | - | 10.9% | -44.3% | - | -82.6% | -4792.9% | -13128.6% | - |
| Net margin | -28.1% | - | -52.9% | -10.0% | -19.4% | - | -162.7% | -7725.0% | -21485.7% | - |
| Free cash flow margin | -11.3% | - | - | - | - | - | - | - | - | - |
| FCF / Net income | 0.40 | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | 0.7% | - | 2.2% | 0.8% | 0.9% | - | 3.6% | 371.4% | 2357.1% | - |
| SG&A / Revenue | 55.6% | - | 69.7% | 50.1% | 87.2% | - | 144.9% | 5264.3% | 14114.3% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -3.2% | - | -3.6% | -1.0% | -1.5% | - | -4.6% | -31.3% | -50.2% | - |
| Return on equity | -15.0% | - | -9.3% | -3.8% | -6.3% | - | 11.1% | 13.4% | 10.1% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.14 | 0.11 | 0.15 | 0.17 | 0.11 | 0.09 | 0.08 | 0.02 | 0.02 | 0.02 |
| Quick ratio | 0.14 | 0.10 | 0.15 | 0.17 | 0.11 | 0.08 | 0.08 | 0.02 | 0.02 | 0.02 |
| Cash ratio | 0.00 | 0.01 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -0.3x | - | -0.9x | 0.6x | -5.1x | - | -6.8x | -3.2x | -28.1x | - |
| Equity multiplier | 4.72 | 4.00 | 2.58 | 3.64 | 4.31 | 7.83 | -2.44 | -0.43 | -0.20 | -0.05 |
| Liabilities / Assets | 0.79 | 0.75 | 0.61 | 0.73 | 0.77 | 0.87 | 1.41 | 3.34 | 5.99 | 20.45 |
| Efficiency | ||||||||||
| Asset turnover | 0.11 | - | 0.07 | 0.10 | 0.08 | - | 0.03 | 0.00 | 0.00 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 276d | - | 325d | 344d | 306d | - | 611d | 3598d | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 63.0% | - | 196.7% | 18537.0% | 45184.6% | - | 11860.0% | -28.2% | -46.2% | - |
| Revenue CAGR (3y) | 635.3% | - | 385.5% | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 82.1% | - | 14.4% | - | -31.2% | - | 71.3% | 79.1% | 84.1% | - |
| Net income growth (YoY) | -135.5% | - | 3.6% | 75.9% | 59.0% | - | 46.8% | 80.8% | 80.3% | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -0.0% | 109.3% | - | - | - | - | -57.7% | -129.4% | -49690.0% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$16.37M totalHealth Cares$16.09M · 98.3%
Life Science Services$252.5K · 1.5%
Corporate And Other$15.1K · 0.1%
Labs$13.9K · 0.1%
Peer comparison
Same SIC group: Services-Commercial Physical & Biological Research
Comparing FOXO TECHNOLOGIES INC. against the 5 most active filers in the same SIC group.